Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France
Table 3
Use of supportive/palliative medications from time of advanced STS diagnosis to death.
United Kingdom
Spain
Germany
France
(%)
(%)
(%)
(%)
Total patients
199
100
203
100
204
100
201
100
Supportive/palliative medication use
Pain control
109
54.8
132
65.0
124
60.8
101
50.3
Antiemetics
88
44.2
121
59.6
102
50
140
69.7
Antibiotics
22
11.1
53
26.1
32
15.7
30
14.9
Antifungals
8
4.0
8
3.9
11
5.4
11
5.5
Antivirals
0
0
5
2.5
2
1.0
0
0
Dexrazoxane
0
0
0
0
0
0
3
1.5
Transfusions
20
10.1
32
15.8
24
11.8
30
14.9
Antianxiety
10
5.0
45
22.2
18
8.8
37
18.4
Growth factors
15
7.5
45
22.2
19
9.3
93
46.3
Erythropoiesis-stimulating agents
0
0.0
8
17.8
0
0.0
23
24.7
Bisphosphonates
1
0.5
5
2.5
4
2.0
12
6.0
Referral to psychiatrist, psychologist, or other professionals for distress management
7
3.5
23
11.3
14
6.9
19
9.5
Oxygen
11
5.5
23
11.3
17
8.3
17
8.5
Radiation therapy, excluding utilization for pain control
4
2.0
16
7.9
3
1.5
7
3.5
Nutritional support
30
15.1
50
24.6
37
18.1
43
21.4
Corticosteroids, except for utilization for pain control
25
12.6
62
30.5
38
18.6
82
40.8
Patient did not receive any supportive care
28
14.1
14
6.9
45
22.1
42
20.9
Others
1
0.5
1
0.5
0
0
1
0.5
Unknown
39
19.6
17
8.4
16
7.8
13
6.5
Treatment for pain control among those who received pain control medications
